Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the κ-opioid receptor

Journal of Neuroimmunology

Volumn 197, Issue 2, 2008, Pages 114-123

  Finley, Matthew J ^a   Chen, Xiaohong ^a   Bardi, Guiseppe ^a   Davey, Penny ^a   Geller, Ellen B ^a   Zhang, Lily ^a   Adler, Martin W ^a   Rogers, Thomas J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokines; Inflammation; Neuroimmunology

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; KAPPA OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM MOBILIZATION; CELL MATURATION; CHEMOTAXIS; DESENSITIZATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLAMMATION; NEUROIMMUNOLOGY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM; CHEMOKINE CXCL12; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYNORPHINS; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HIV-1; HUMANS; NEUTROPHILS; PERIAQUEDUCTAL GRAY; PROTEIN TRANSPORT; RATS; RECEPTORS, CXCR4; RECEPTORS, OPIOID, KAPPA; TIME FACTORS; TRANSFECTION;

EID: 46649100868     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.04.021     Document Type: Article

References (69)

1. Ali H., Richardson R.M., Haribabu B., and Snyderman R. Chemoattractant receptor cross-desensitization. [Review] [52 refs]. J. Biol. Chem. 274 no. 10 (1999) 6027-6030
2. Alicea C., Belkowski S., Eisenstein T.K., Adler M.W., and Rogers T.J. Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50,488H. J. Neuroimmunol. 64 no. 1 (1996) 83-90
3. Baggiolini M., Dewald B., and Moser B. Human chemokines: an update. [Review] [181 refs]. Annu. Rev. Immunol. 15 (1997) 675-705
4. Bagri A., Gurney T., He X., Zou Y.R., Littman D.R., Tessier-Lavigne M., and Pleasure S.J. The chemokine SDF1 regulates migration of dentate granule cells. Development 129 no. 18 (2002) 4249-4260
5. Balabanian K., Lagane B., Infantino S., Chow K.Y., Harriague J., Moepps B., renzana-Seisdedos F., Thelen M., and Bachelerie F. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280 no. 42 (2005) 35760-35766
6. Belkowski S.M., Zhu J., Liu-Chen L.Y., Eisenstein T.K., Adler M.W., and Rogers T.J. Sequence of kappa-opioid receptor cDNA in the R1.1 thymoma cell line. J. Neuroimmunol. 62 no. 1 (1995) 113-117
7. Bernhagen J., Krohn R., Lue H., Gregory J.L., Zernecke A., Koenen R.R., Dewor M., Georgiev I., Schober A., Leng L., Kooistra T., Fingerle-Rowson G., Ghezzi P., Kleemann R., McColl S.R., Bucala R., Hickey M.J., and Weber C. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13 no. 5 (2007) 587-596
8. Bidlack J.M., Saripalli L.D., and Lawrence D.M. Kappa-opioid binding sites on a murine lymphoma cell line. Eur. J. Pharmacol. 227 no. 3 (1992) 257-265
9. Buckley C.D., Amft N., Bradfield P.F., Pilling D., Ross E., Arenzana-Seisdedos F., Amara A., Curnow S.J., Lord J.M., Scheel-Toellner D., and Salmon M. Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J. Immunol. 165 no. 6 (2000) 3423-3429
10. Carr D.J., DeCosta B.R., Kim C.H., Jacobson A.E., Guarcello V., Rice K.C., and Blalock J.E. Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes. J. Endocrinol. 122 no. 1 (1989) 161-168
11. Carr D.J., Rogers T.J., and Weber R.J. The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis. [Review] [97 refs]. Proc. Soc. Exp. Biol. Med. 213 no. 3 (1996) 248-257
12. Chen Y., Mestek A., Liu J., Hurley J.A., and Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol. Pharmacol. 44 no. 1 (1993) 8-12
13. Chen X., Geller E.B., Rogers T.J., and Adler M.W. Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats. Drug Alcohol Depend. 88 no. 1 (2007) 36-41
14. Chuang L.F., Chuang T.K., Killam Jr. K.F., Chuang A.J., Kung H.F., Yu L., and Chuang R.Y. Delta opioid receptor gene expression in lymphocytes. Biochem. Biophys. Res. Commun. 202 no. 3 (1994) 1291-1299
15. De C.E. The bicyclam AMD3100 story. [Review] [50 refs]. Nat. Rev. 2 no. 7 (2003) 581-587 Drug Discovery
16. Deng X., Ueda H., Su S.B., Gong W., Dunlop N.M., Gao J.L., Murphy P.M., and Wang J.M. A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R. Blood 94 no. 4 (1999) 1165-1173
17. Dziembowska M., Tham T.N., Lau P., Vitry S., Lazarini F., and Dubois-Dalcq M. A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia 50 no. 3 (2005) 258-269
18. Eddleston J., Christiansen S.C., and Zuraw B.L. Functional expression of the C-X-C chemokine receptor CXCR4 by human bronchial epithelial cells: regulation by proinflammatory mediators. J. Immunol. 169 no. 11 (2002) 6445-6451
19. Evans C.J., Keith Jr. D., Morrison H., Magendzo K., and Edwards R.H. Cloning of a delta opioid receptor by functional expression [see comments]. Science 258 no. 5090 (1992) 1952-1955
20. Feil C., and Augustin H.G. Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. Biochem. Biophys. Res. Commun. 247 no. 1 (1998) 38-45
21. Gerard C., and Rollins B.J. Chemokines and disease. [Review] [118 refs]. Nat. Immunol. 2 no. 2 (2001) 108-115
22. Gonzalo J.A., Lloyd C.M., Peled A., Delaney T., Coyle A.J., and Gutierrez-Ramos J.C. Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J. Immunol. 165 no. 1 (2000) 499-508
23. Grimm M.C., Ben Baruch A., Taub D.D., Howard O.M., Resau J.H., Wang J.M., Ali H., Richardson R., Snyderman R., and Oppenheim J.J. Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. J. Exp. Med. 188 no. 2 (1998) 317-325
24. Hassan A.H., Pzewlocki R., Herz A., and Stein C. Dynorphin, a preferential ligand for kappa-opioid receptors, is present in nerve fibers and immune cells within inflamed tissue of the rat. Neurosci. Lett. 140 no. 1 (1992) 85-88
25. Hecht I., Cahalon L., Hershkoviz R., Lahat A., Franitza S., and Lider O. Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis. Int. Immunol. 15 no. 1 (2003) 29-38
26. Hesselgesser J., Halks-Miller M., DelVecchio V., Peiper S.C., Hoxie J., Kolson D.L., Taub D., and Horuk R. CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr. Biol. 7 no. 2 (1997) 112-121
27. Honczarenko M., Le Y., Glodek A.M., Majka M., Campbell J.J., Ratajczak M.Z., and Silberstein L.E. CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor. Blood 100 no. 7 (2002) 2321-2329
28. Kieffer B.L., Befort K., Gaveriaux-Ruff C., and Hirth C.G. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization [published erratum appears in Proc Natl Acad Sci U S A 1994 Feb 1;91(3):1193]. Proc. Natl. Acad. Sci. U. S. A. 89 no. 24 (1992) 12048-12052
29. Klein R.S., Rubin J.B., Gibson H.D., DeHaan E.N., Alvarez-Hernandez X., Segal R.A., and Luster A.D. SDF-1 alpha induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells. Development - Supplement 128 no. 11 (2001) 1971-1981
30. Kulkarni-Narla A., Walcheck B., and Brown D.R. Opioid receptors on bone marrow neutrophils modulate chemotaxis and CD11b/CD18 expression. Eur. J. Pharmacol. 414 no. 2-3 (2001) 289-294
31. Lefkowitz R.J. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. [Review] [47 refs]. J. Biol. Chem. 273 no. 30 (1998) 18677-18680
32. Li S., Zhu J., Chen C., Chen Y.W., Deriel J.K., Ashby B., and Liu-Chen L.Y. Molecular cloning and expression of a rat kappa opioid receptor. Biochem. J. 295 no. Pt 3 (1993) 629-633
33. Li B.Q., Wetzel M.A., Mikovits J.A., Henderson E.E., Rogers T.J., Gong W., Le Y., Ruscetti F.W., and Wang J.M. The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1. Blood 97 10 (2001) 2941-2947
34. Li J.G., Zhang F., Jin X.L., and Liu-Chen L.Y. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation. J. Pharmacol. Exp. Ther. 305 no. 2 (2003) 531-540
35. Loetscher M., Geiser T., O'Reilly T., Zwahlen R., Baggiolini M., and Moser B. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 269 no. 1 (1994) 232-237
36. Ma Q., Jones D., Borghesani P.R., Segal R.A., Nagasawa T., Kishimoto T., Bronson R.T., and Springer T.A. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 95 no. 16 (1998) 9448-9453
37. McCarthy L., Wetzel M., Sliker J.K., Eisenstein T.K., and Rogers T.J. Opioids, opioid receptors, and the immune response. [Review] [128 refs]. Drug Alcohol Depend. 62 no. 2 (2001) 111-123
38. Messersmith D.J., Gu J., Dubner R., Douglass J., and Iadarola M.J. Basal and inducible transcriptional activity of an upstream AP-1/CRE element (DYNCRE3) in the prodynorphin promoter. Mol. Cell. Neurosci. 5 no. 3 (1994) 238-245
39. Moore J.P., Trkola A., and Dragic T. Co-receptors for HIV-1 entry [see comments]. [Review] [93 refs]. Curr. Opin. Immunol. 9 no. 4 (1997) 551-562
40. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., and Power C.A. International union of pharmacology. XXII. Nomenclature for chemokine receptors. [Review] [520 refs]. Pharmacol. Rev. 52 no. 1 (2000) 145-176
41. Nanki T., Hayashida K., El Gabalawy H.S., Suson S., Shi K., Girschick H.J., Yavuz S., and Lipsky P.E. Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J. Immunol. 165 no. 11 (2000) 6590-6598
42. Ohtani Y., Minami M., Kawaguchi N., Nishiyori A., Yamamoto J., Takami S., and Satoh M. Expression of stromal cell-derived factor-1 and CXCR4 chemokine receptor mRNAs in cultured rat glial and neuronal cells. Neurosci. Lett. 249 no. 2-3 (1998) 163-166
43. Olbrich H., Proudfoot A.E., and Oppermann M. Chemokine-induced phosphorylation of CC chemokine receptor 5 (CCR5). [Review] [36 refs]. J. Leukoc. Biol. 65 no. 3 (1999) 281-285
44. Paxinos G.A.W.C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, San Diego Ref Type: Generic
45. Pellegrino L.J., and Cushman A.J. A stereotaxic Atlas of the Rat Brain (1967), Appleton-Century-Crofts, New York Ref Type: Generic
46. Pizziketti R.J., Pressman N.S., Geller E.B., Cowan A., and Adler M.W. Rat cold water tail-flick: a novel analgesic test that distinguishes opioid agonists from mixed agonist-antagonists. Eur. J. Pharmacol. 119 no. 1-2 (1985) 23-29
47. Proudfoot A.E., Wells T.N., and Clapham P.R. Chemokine receptors-future therapeutic targets for HIV?. [Review] [123 refs]. Biochem. Pharmacol. 57 no. 5 (1999) 451-463
48. Richardson R.M., Tokunaga K., Marjoram R., Sata T., and Snyderman R. Interleukin-8-mediated heterologous receptor internalization provides resistance to HIV-1 infectivity. Role of signal strength and receptor desensitization. J. Biol. Chem. 278 no. 18 (2003) 15867-15873
49. Rogers T.J., and Peterson P.K. Opioid G protein-coupled receptors: signals at the crossroads of inflammation. [Review] [43 refs]. Trends Immunol. 24 no. 3 (2003) 116-121
50. Rogers T.J., Steele A.D., Howard O.M., and Oppenheim J.J. Bidirectional heterologous desensitization of opioid and chemokine receptors. [Review] [51 refs]. Ann. N.Y. Acad. Sci. 917 (2000) 19-28
51. Ruda M.A., Iadarola M.J., Cohen L.V., and Young III W.S. In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia. Proc. Natl. Acad. Sci. U. S. A. 85 no. 2 (1988) 622-626
52. Schafer M., Carter L., and Stein C. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc. Natl. Acad. Sci. U. S. A. 91 no. 10 (1994) 4219-4223
53. Sedqi M., Roy S., Ramakrishnan S., Elde R., and Loh H.H. Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 209 no. 2 (1995) 563-574
54. Steele A.D., Szabo I., Bednar F., and Rogers T.J. Interactions between opioid and chemokine receptors: heterologous desensitization. [Review] [142 refs]. Cytokine Growth Factor Rev. 13 no. 3 (2002) 209-222
55. Steele A.D., Henderson E.E., and Rogers T.J. Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology 309 no. 1 (2003) 99-107
56. Stumm R., and Hollt V. CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain. J. Mol. Endocrinol. 38 no. 3 (2007) 377-382
57. Stumm R.K., Zhou C., Ara T., Lazarini F., Dubois-Dalcq M., Nagasawa T., Hollt V., and Schulz S. CXCR4 regulates interneuron migration in the developing neocortex. J. Neurosci. 23 no. 12 (2003) 5123-5130
58. Szabo I., Chen X.H., Xin L., Adler M.W., Howard O.M., Oppenheim J.J., and Rogers T.J. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc. Natl. Acad. Sci. U. S. A. 99 no. 16 (2002) 10276-10281
59. Szabo I., Wetzel M.A., Zhang N., Steele A.D., Kaminsky D.E., Chen C., Liu-Chen L.Y., Bednar F., Henderson E.E., Howard O.M., Oppenheim J.J., and Rogers T.J. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization. J. Leukoc. Biol. 74 no. 6 (2003) 1074-1082
60. Tanabe S., Heesen M., Yoshizawa I., Berman M.A., Luo Y., Bleul C.C., Springer T.A., Okuda K., Gerard N., and Dorf M.E. Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J. Immunol. 159 no. 2 (1997) 905-911
61. Tham T.N., Lazarini F., Franceschini I.A., Lachapelle F., Amara A., and Dubois-Dalcq M. Developmental pattern of expression of the alpha chemokine stromal cell-derived factor 1 in the rat central nervous system. Eur. J. Neurosci. 13 no. 5 (2001) 845-856
62. Tran P.B., and Miller R.J. Chemokine receptors: signposts to brain development and disease. [Review] [126 refs]. Nat. Rev. Neurosci. 4 no. 6 (2003) 444-455
63. Tran P.B., Banisadr G., Ren D., Chenn A., and Miller R.J. Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain. J. Comp. Neurol. 500 no. 6 (2007) 1007-1033
64. Volin M.V., Joseph L., Shockley M.S., and Davies P.F. Chemokine receptor CXCR4 expression in endothelium. Biochem. Biophys. Res. Commun. 242 no. 1 (1998) 46-53
65. Xin L., Geller E.B., Liu-Chen L.Y., Chen C., and Adler M.W. Substance P release in the rat periaqueductal gray and preoptic anterior hypothalamus after noxious cold stimulation: effect of selective mu and kappa opioid agonists. J. Pharmacol. Exp. Ther. 282 no. 2 (1997) 1055-1063
66. Yasuda K., Raynor K., Kong H., Breder C.D., Takeda J., Reisine T., and Bell G.I. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc. Natl. Acad. Sci. U. S. A. 90 no. 14 (1993) 6736-6740
67. Zhang N., Hodge D., Rogers T.J., and Oppenheim J.J. Ca2+-independent protein kinase Cs mediate heterologous desensitization of leukocyte chemokine receptors by opioid receptors. J. Biol. Chem. 278 no. 15 (2003) 12729-12736
68. Zhang N., Rogers T.J., Caterina M., and Oppenheim J.J. Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons. J. Immunol. 173 no. 1 (2004) 594-599
69. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., and Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development [see comments]. Nature 393 no. 6685 (1998) 595-599